Difference between revisions of "Vendor:Cannevert Therapeutics Ltd."
From LIMSWiki
Jump to navigationJump to searchShawndouglas (talk | contribs) (Updated due to website changes) Tag: Manual revert |
Shawndouglas (talk | contribs) (Saving and adding more.) |
||
| Line 2: | Line 2: | ||
|company_name = '''Cannevert Therapeutics Ltd.''' | |company_name = '''Cannevert Therapeutics Ltd.''' | ||
|company_logo = | |company_logo = | ||
|company_type = Incorporated ( | |company_type = Incorporated (inc.) | ||
|traded_as = | |traded_as = | ||
|industry = [[Cannabis industry]] | |industry = [[Cannabis industry]] | ||
|genre = ''Cannabis'' testing | |genre = ''Cannabis'' testing | ||
|fate = | |fate = | ||
|predecessor = | |predecessor = | ||
| Line 12: | Line 12: | ||
|foundation = | |foundation = | ||
|founder = | |founder = | ||
|defunct = | |defunct = | ||
|location_city = | |location_city = #322 - 2250 Lower Mall, Vancouver, British Columbia | ||
|location_country = Canada | |location_country = Canada | ||
|locations = 1 | |locations = 1 | ||
| Line 20: | Line 20: | ||
|products = | |products = | ||
|production = | |production = | ||
|services = ''Cannabis'' testing | |services = ''Cannabis'' testing | ||
|revenue = | |revenue = | ||
|operating_income = | |operating_income = | ||
| Line 29: | Line 29: | ||
|owner = | |owner = | ||
|num_employees = | |num_employees = | ||
|parent = | |parent = | ||
|divisions = | |divisions = | ||
|subsid = | |subsid = | ||
|homepage = [ | |homepage = [https://anandia.ca/ anandia.ca] | ||
|linkedin = | |linkedin = [https://www.linkedin.com/company/anandia-labs/ https://www.linkedin.com/company/anandia-labs/] | ||
|footnotes = | |footnotes = | ||
|intl = No | |intl = No | ||
}} | }} | ||
'''Cannevert Therapeutics Ltd.''' | '''Cannevert Therapeutics Ltd.''' performs chemical ''[[Cannabis]]'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web |url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html |title=Laboratories licensed to conduct activities with cannabis |work=Health Canada |publisher=Government of Canada |date=17 August 2018 |accessdate=27 June 2019}}</ref> | ||
==History== | ==History== | ||
The company was formally founded in June 2014.<ref name="CACLACan">{{cite web |url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active |title=Cannevert Therapeutics Ltd |work=Canada's Business Registries |publisher=Canadian Association of Corporate Law Administrators |accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web |url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ |title=Veritas Presents Its Key Cannevert Scientists |publisher=Veritas Pharma, Inc |date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web |url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html |title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics |author=Veritas Pharma, Inc |work=TheNewswire |date=25 January 2017 |accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web |url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html |title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics |author=Veritas Pharma, Inc |work=GlobeNewswire |date=21 March 2018 |accessdate=28 June 2019}}</ref> | The company was formally founded in June 2014.<ref name="CACLACan">{{cite web |url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active |title=Cannevert Therapeutics Ltd |work=Canada's Business Registries |publisher=Canadian Association of Corporate Law Administrators |accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web |url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ |title=Veritas Presents Its Key Cannevert Scientists |publisher=Veritas Pharma, Inc |date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web |url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html |title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics |author=Veritas Pharma, Inc |work=TheNewswire |date=25 January 2017 |accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web |url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html |title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics |author=Veritas Pharma, Inc |work=GlobeNewswire |date=21 March 2018 |accessdate=28 June 2019}}</ref> In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name="GNWVeritas19">{{cite web |url=https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html |title=Veritas Announces Restructuring of Cannevert Therapeutics Ltd. |author=Veritas Pharma, Inc |work=GlobeNewswire |date=15 May 2019 |accessdate=28 June 2019}}</ref> | ||
==Locations== | |||
The following laboratory locations are known. Services may vary among locations: | |||
* [https://anandia.ca/contact/ Anandia Laboratories] - Vancouver, British Columbia | |||
==Pricing== | |||
The company doesn't make its cannabis testing pricing public. | |||
==Additional information== | ==Additional information== | ||
* [https://anandia.ca/#services Anandia services] | |||
==References== | ==References== | ||
| Line 52: | Line 58: | ||
<!---Place all category tags here--> | <!---Place all category tags here--> | ||
[[Category: | [[Category:Cannabis testing laboratories]] | ||
[[Category:Labs in British Columbia]] | |||
[[Category:Labs in Canada]] | |||
[[Category:Vendors]] | |||
Revision as of 17:18, 28 December 2023
| Type | Incorporated (inc.) |
|---|---|
| Industry | Cannabis industry |
| Genre | Cannabis testing |
| Headquarters | #322 - 2250 Lower Mall, Vancouver, British Columbia, Canada |
| Number of locations | 1 |
| Area served | Canada |
| Key people | John Coleman |
| Services | Cannabis testing |
| Website | anandia.ca |
| https://www.linkedin.com/company/anandia-labs/ |
Cannevert Therapeutics Ltd. performs chemical Cannabis laboratory testing for the country's various cannabis programs.[1]
History
The company was formally founded in June 2014.[2] In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.[3] By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.[4] In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."[5] In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of Cannabis.[6]
Locations
The following laboratory locations are known. Services may vary among locations:
- Anandia Laboratories - Vancouver, British Columbia
Pricing
The company doesn't make its cannabis testing pricing public.
Additional information
References
- ↑ "Laboratories licensed to conduct activities with cannabis". Health Canada. Government of Canada. 17 August 2018. https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html. Retrieved 27 June 2019.
- ↑ "Cannevert Therapeutics Ltd". Canada's Business Registries. Canadian Association of Corporate Law Administrators. https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active. Retrieved 28 June 2019.
- ↑ "Veritas Presents Its Key Cannevert Scientists". Veritas Pharma, Inc. 16 February 2016. http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/.
- ↑ Veritas Pharma, Inc (25 January 2017). "Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics". TheNewswire. https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html. Retrieved 28 June 2019.
- ↑ Veritas Pharma, Inc (21 March 2018). "Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics". GlobeNewswire. https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html. Retrieved 28 June 2019.
- ↑ Veritas Pharma, Inc (15 May 2019). "Veritas Announces Restructuring of Cannevert Therapeutics Ltd.". GlobeNewswire. https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html. Retrieved 28 June 2019.
